| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/24/2007 | CA2254848C Methods for sterilizing male mammals |
| 04/24/2007 | CA2243708C Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 04/24/2007 | CA2242768C Activatable infusable dispersions and methods for using them for therapy and diagnostics |
| 04/24/2007 | CA2212113C Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
| 04/24/2007 | CA2184345C Coordinate in vivo gene expression |
| 04/24/2007 | CA2179584C Pharmaceutical composition containing insulin sensitivity enhancer in combination with another antidiabetic |
| 04/24/2007 | CA2138451C Sugar-coated pharmaceutical dosage unit |
| 04/24/2007 | CA2106827C Pharmaceutical compositions containing cyclosporins |
| 04/19/2007 | WO2007044968A2 Stable, durable granules with active agents |
| 04/19/2007 | WO2007044748A2 Sphingomyelin liposomes for the treatment of hyperactive bladder disorders |
| 04/19/2007 | WO2007044681A2 Reduction of saltiness with sweeteners |
| 04/19/2007 | WO2007044511A1 Fiber satiety compositions |
| 04/19/2007 | WO2007044488A1 Enteric soft capsule comprising valproic acid |
| 04/19/2007 | WO2007044234A1 Osmotic dosage form with controlled release and fast release aspects |
| 04/19/2007 | WO2007044062A1 Bile preparations for gastrointestinal disorders |
| 04/19/2007 | WO2007043702A1 Agent for applying to mucosa and method for production thereof |
| 04/19/2007 | WO2007043605A1 Iontophoresis apparatus sticking to mucosa |
| 04/19/2007 | WO2007043580A1 Iontophoresis preparation for treatment of breast cancer and/or mastitis |
| 04/19/2007 | WO2007043538A1 Composition for oral administration |
| 04/19/2007 | WO2007043486A1 Biocompatible block copolymer, use thereof, and production method thereof |
| 04/19/2007 | WO2007043429A1 Face head pad for iontophoresis device, and iontophoresis apparatus comprising the same |
| 04/19/2007 | WO2007043074A1 Liposomes loaded with fullerene and process for their preparation |
| 04/19/2007 | WO2007043061A1 Anti-malarial combination and methods of formulation |
| 04/19/2007 | WO2007043057A2 Compositions for nasal delivery |
| 04/19/2007 | WO2007042961A2 Device for controlled release of chemical molecules |
| 04/19/2007 | WO2007042925A2 A composition for the treatment of diabetic periodontitis |
| 04/19/2007 | WO2007042833A2 Arnphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents |
| 04/19/2007 | WO2007042745A1 Chocolate based appetite suppressant |
| 04/19/2007 | WO2007042682A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
| 04/19/2007 | WO2007042572A1 Chitosan and heparin nanoparticles |
| 04/19/2007 | WO2007042445A1 Method for the production of directly compressible ibuprofen formulations |
| 04/19/2007 | WO2007042281A2 Processing of chitosan and chitosan derivatives |
| 04/19/2007 | WO2007042262A2 Ophthalmic emulsions containing prostaglandins |
| 04/19/2007 | WO2007042160A1 Retard formulation for pralnacasan |
| 04/19/2007 | WO2007042034A1 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 04/19/2007 | WO2007041832A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 04/19/2007 | WO2007022056A3 Sensation masking composition |
| 04/19/2007 | WO2007021189A3 Method of treating parturient placental mammals in order to reduce maternal and/or utirine exhaustion |
| 04/19/2007 | WO2007019845A3 Method for encapsulating therapeutic substances in cells |
| 04/19/2007 | WO2007017895A3 Stabilized oral pharmaceutical compositions of cephalosporins |
| 04/19/2007 | WO2007017028A3 Tablets with improved dissolution profile |
| 04/19/2007 | WO2007017028A2 Tablets with improved dissolution profile |
| 04/19/2007 | WO2007015270A3 Novel controlled release compositions of selective serotonin reuptake inhibitors |
| 04/19/2007 | WO2007012625A8 Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 04/19/2007 | WO2007012539A3 Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 04/19/2007 | WO2007010369A3 Sustained release formulation of alprazolam |
| 04/19/2007 | WO2007009012A3 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
| 04/19/2007 | WO2006133901A3 Production of colloidal active substance or vital substance species by nanoscalar reactive desorption |
| 04/19/2007 | WO2006127742A9 Indicia bearing package for delivery systems |
| 04/19/2007 | WO2006127741A9 Indicia-bearing package for delivery systems for managing release of sensates in an edible composition |
| 04/19/2007 | WO2006127616A3 Indicia-bearing package for delivery systems for managing release of flavors in an edible composition |
| 04/19/2007 | WO2006124584A3 Multilayer drug delivery system with barrier against reservoir material flow |
| 04/19/2007 | WO2006123354B1 Oral pharmaceutical composition |
| 04/19/2007 | WO2006117139A3 Solid transdermal therapeutic system comprising uv absorber |
| 04/19/2007 | WO2006114448A3 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 04/19/2007 | WO2006105741B1 Topical pharmaceutical formulation containing nimesulide |
| 04/19/2007 | WO2006086654A3 Nanoformulations |
| 04/19/2007 | WO2006062931A3 Medical combinations |
| 04/19/2007 | WO2006060723A3 Methods for producing block copolymer/amphiphilic particles |
| 04/19/2007 | WO2006055532A3 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 04/19/2007 | WO2006024095A8 Microemulsion & sub-micron emulsion process & compositions |
| 04/19/2007 | WO2006015178A3 Growth factor encapsulation system for enhancing bone formation |
| 04/19/2007 | WO2006010457A3 Method for producing coated drugs having a stable profile for the release of active ingredients |
| 04/19/2007 | WO2005120466A3 Sugar coatings and methods therefor |
| 04/19/2007 | WO2005076697A3 Cosmetic and pharmaceutical foam with solid matter |
| 04/19/2007 | WO2005074899A3 New compositions containing quinoline compounds |
| 04/19/2007 | WO2004098537A3 Activation agents on the surface of encapsulation vesicles |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070088338 Method for control of the volume flux of a liquid in an osmotic micropump and osmotic micropump |
| 04/19/2007 | US20070088337 Minimally compliant, volume efficient piston for osmotic drug delivery systems |
| 04/19/2007 | US20070088336 Implantable drug delivery depot for subcutaneous delivery of fluids |
| 04/19/2007 | US20070088335 Implantable neuro-stimulation electrode with fluid reservoir |
| 04/19/2007 | US20070088334 Controllable release nasal system |
| 04/19/2007 | US20070088333 Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate |
| 04/19/2007 | US20070088332 Iontophoresis device |
| 04/19/2007 | US20070088331 Method and apparatus for managing active agent usage, and active agent injecting device |
| 04/19/2007 | US20070088298 Cartridge-based portable device for dispensing skin treatments |
| 04/19/2007 | US20070088077 Appetite stimulation and reduction of weight loss in patients suffering from symptomatic hiv infection |
| 04/19/2007 | US20070088005 Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 04/19/2007 | US20070088000 Beta-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 04/19/2007 | US20070087999 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 04/19/2007 | US20070087963 Synthesis of cyclosporin analogs |
| 04/19/2007 | US20070087958 Compounds and compositions for delivering active agents |
| 04/19/2007 | US20070087939 Biopolymer compositions and products thereof |
| 04/19/2007 | US20070087060 Ultrasound coupling medium for use in medical diagnostics |
| 04/19/2007 | US20070087059 Bioactive delivery matrix compositions and methods |
| 04/19/2007 | US20070087058 Osmotic implant with membrane and membrane retention means |
| 04/19/2007 | US20070087057 Hydrogel-Driven Drug Dosage Form |
| 04/19/2007 | US20070087056 Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility |
| 04/19/2007 | US20070087055 Directly compressible extended release alprazolam formulation |
| 04/19/2007 | US20070087054 Effervescent formulations of oxytocin |
| 04/19/2007 | US20070087053 Lozenge for treatment of dry mouth and related conditions |
| 04/19/2007 | US20070087052 Effervescent bisphosphonate formulation |
| 04/19/2007 | US20070087051 Pharmaceutical composition |
| 04/19/2007 | US20070087050 Orally Disintegratable Simvastatin Tablets |
| 04/19/2007 | US20070087049 Comprising two or more connected sub-units, particularly for oral dosing, comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected in the assembled dosage form by a weld |
| 04/19/2007 | US20070087048 Oral dosage combination pharmaceutical packaging |
| 04/19/2007 | US20070087047 Enhanced circulation effector composition and method |
| 04/19/2007 | US20070087046 Use of green porphyrins to treat neovasculature in the eye |
| 04/19/2007 | US20070087045 Lipid carrier and method of preparing the same |